John Newman
Stock Analyst at Canaccord Genuity
(2.65)
# 2,916
Out of 4,993 analysts
934
Total ratings
43.1%
Success rate
1%
Average return
Main Sectors:
Stocks Rated by John Newman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences | Maintained: Buy | $50 | $25.65 | +94.93% | 16 | Sep 22, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $136 | $98.00 | +38.78% | 27 | Sep 15, 2026 | |
| ACET Adicet Bio | Reiterated: Buy | $18 | $8.99 | +100.22% | 32 | Sep 11, 2026 | |
| TNGX Tango Therapeutics | Reiterated: Buy | $46 | $22.33 | +106.00% | 12 | Sep 11, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Reiterated: Buy | $23 → $20 | $4.66 | +329.18% | 5 | Sep 9, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | $7 | $1.82 | +284.62% | 15 | Sep 1, 2026 | |
| KZIA Kazia Therapeutics | Reiterated: Buy | $29 | $10.65 | +172.30% | 2 | Sep 1, 2026 | |
| INCY Incyte | Initiated Coverage: Buy | $152 | $124.65 | +21.94% | 1 | Aug 21, 2026 | |
| MRKR Marker Therapeutics | Reiterated: Buy | $8 | $1.21 | +563.90% | 15 | Aug 17, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $14 | $1.69 | +728.40% | 38 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $9.38 | +38.59% | 91 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $11.21 | +123.02% | 13 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $16.11 | +30.35% | 30 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.01 | +791.09% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $4.07 | +440.54% | 69 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $18.19 | +59.43% | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $25.03 | +51.82% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $875 | $798.17 | +9.63% | 118 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $5.22 | n/a | 18 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.7663 | n/a | 19 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $300 | $10.22 | n/a | 34 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $7.94 | n/a | 45 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $44 | $33.95 | n/a | 57 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $3 | $0.0007 | n/a | 24 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $353.05 | $22.46 | n/a | 2 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $28.43 | n/a | 1 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $14.48 | n/a | 25 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.7902 | n/a | 12 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13.99 | $8.56 | n/a | 1 | Mar 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $1.35 | n/a | 18 | Jun 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $6 | $1.67 | n/a | 18 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $38.99 | n/a | 17 | Jun 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $16.61 | n/a | 10 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $16.25 | n/a | 11 | Mar 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $10.86 | n/a | 12 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $60 | $0.81 | n/a | 13 | Nov 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $15 | $2.24 | n/a | 4 | Oct 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $11.67 | n/a | 17 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $5.45 | n/a | 9 | Jul 26, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 | $30.25 | n/a | 1 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $3.27 | n/a | 1 | May 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $31.13 | n/a | 1 | May 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $1,043.96 | n/a | 1 | Mar 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $6 | $1.17 | n/a | 5 | Mar 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $201 | $241.46 | n/a | 5 | Mar 3, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $8.90 | n/a | 1 | Jan 7, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $9 | $14.69 | n/a | 3 | Oct 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $127 | $219.07 | n/a | 45 | Dec 20, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 | $3.50 | n/a | 2 | Mar 15, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $66.00 | n/a | 1 | Jun 10, 2009 |
Tyra Biosciences
Sep 22, 2026
Maintained: Buy
Price Target: $50
Current: $25.65
Upside: +94.93%
BioNTech SE
Sep 15, 2026
Reiterated: Buy
Price Target: $136
Current: $98.00
Upside: +38.78%
Adicet Bio
Sep 11, 2026
Reiterated: Buy
Price Target: $18
Current: $8.99
Upside: +100.22%
Tango Therapeutics
Sep 11, 2026
Reiterated: Buy
Price Target: $46
Current: $22.33
Upside: +106.00%
BridgeBio Oncology Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $23 → $20
Current: $4.66
Upside: +329.18%
Compass Therapeutics
Sep 1, 2026
Reiterated: Buy
Price Target: $7
Current: $1.82
Upside: +284.62%
Kazia Therapeutics
Sep 1, 2026
Reiterated: Buy
Price Target: $29
Current: $10.65
Upside: +172.30%
Incyte
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $152
Current: $124.65
Upside: +21.94%
Marker Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $8
Current: $1.21
Upside: +563.90%
Allogene Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $14
Current: $1.69
Upside: +728.40%
Aug 13, 2026
Reiterated: Buy
Price Target: $13
Current: $9.38
Upside: +38.59%
Aug 13, 2026
Reiterated: Buy
Price Target: $25
Current: $11.21
Upside: +123.02%
Aug 11, 2026
Reiterated: Buy
Price Target: $21
Current: $16.11
Upside: +30.35%
Aug 6, 2026
Reiterated: Buy
Price Target: $9
Current: $1.01
Upside: +791.09%
Aug 6, 2026
Reiterated: Buy
Price Target: $22
Current: $4.07
Upside: +440.54%
Aug 6, 2026
Reiterated: Buy
Price Target: $29
Current: $18.19
Upside: +59.43%
Aug 5, 2026
Reiterated: Buy
Price Target: $38
Current: $25.03
Upside: +51.82%
Jul 22, 2026
Reiterated: Buy
Price Target: $875
Current: $798.17
Upside: +9.63%
Nov 12, 2024
Reiterated: Buy
Price Target: $10
Current: $5.22
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: $5
Current: $0.7663
Upside: n/a
Oct 1, 2024
Reiterated: Buy
Price Target: $6 → $300
Current: $10.22
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $43
Current: $7.94
Upside: n/a
Feb 16, 2022
Reiterated: Buy
Price Target: $52 → $44
Current: $33.95
Upside: n/a
Aug 17, 2021
Reiterated: Buy
Price Target: $7 → $3
Current: $0.0007
Upside: n/a
May 26, 2021
Reiterated: Buy
Price Target: $353.05
Current: $22.46
Upside: n/a
May 12, 2021
Reiterated: Buy
Price Target: $31
Current: $28.43
Upside: n/a
May 3, 2021
Reiterated: Buy
Price Target: $45
Current: $14.48
Upside: n/a
Mar 25, 2021
Reiterated: Buy
Price Target: $5
Current: $0.7902
Upside: n/a
Mar 9, 2020
Reiterated: Buy
Price Target: $13.99
Current: $8.56
Upside: n/a
Jun 26, 2019
Reiterated: Buy
Price Target: $20
Current: $1.35
Upside: n/a
Aug 13, 2018
Reiterated: Buy
Price Target: $31 → $6
Current: $1.67
Upside: n/a
Jun 27, 2017
Reiterated: Buy
Price Target: $8 → $5
Current: $38.99
Upside: n/a
Mar 10, 2017
Reiterated: Buy
Price Target: $10
Current: $16.61
Upside: n/a
Mar 1, 2017
Reiterated: Buy
Price Target: $12
Current: $16.25
Upside: n/a
Dec 30, 2016
Reiterated: Buy
Price Target: $10
Current: $10.86
Upside: n/a
Nov 9, 2016
Reiterated: Buy
Price Target: $6 → $60
Current: $0.81
Upside: n/a
Oct 11, 2016
Reiterated: Buy
Price Target: $6 → $15
Current: $2.24
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $34
Current: $11.67
Upside: n/a
Jul 26, 2016
Reiterated: Buy
Price Target: $3
Current: $5.45
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $90
Current: $30.25
Upside: n/a
May 13, 2016
Reiterated: Buy
Price Target: $30
Current: $3.27
Upside: n/a
May 2, 2016
Reiterated: Buy
Price Target: $26
Current: $31.13
Upside: n/a
Mar 31, 2016
Reiterated: Buy
Price Target: $18
Current: $1,043.96
Upside: n/a
Mar 9, 2015
Reiterated: Hold
Price Target: $8 → $6
Current: $1.17
Upside: n/a
Mar 3, 2015
Reiterated: Buy
Price Target: $201
Current: $241.46
Upside: n/a
Jan 7, 2015
Initiated Coverage: Buy
Price Target: $24
Current: $8.90
Upside: n/a
Oct 7, 2014
Downgraded: Hold
Price Target: $40 → $9
Current: $14.69
Upside: n/a
Dec 20, 2011
Rated: Buy
Price Target: $127
Current: $219.07
Upside: n/a
Mar 15, 2010
Downgraded: Sell
Price Target: $5
Current: $3.50
Upside: n/a
Jun 10, 2009
Reiterated: Sell
Price Target: n/a
Current: $66.00
Upside: n/a